STOCK TITAN

Nitches (NICH) Stock News

NICH OTC

Welcome to our dedicated page for Nitches news (Ticker: NICH), a resource for investors and traders seeking the latest updates and insights on Nitches stock.

Nitches Inc. reports on its human performance and wellness platform, with recurring updates centered on InTheZone Labs, its wholly owned subsidiary. Company news focuses on nootropic and nutraceutical products for brain health, recovery, focus, energy and wellness, along with domestic formulation, quality controls and compliant marketing.

Updates also cover affiliate and distributor expansion through social-commerce and online channels, GovX-supported programs for service communities, subsidiary commercialization plans, and the company's audit and reporting-status initiatives.

Rhea-AI Summary

Nitches (OTC:NICH) reports that its NutraVeri supplement-technology platform, built from its experience formulating and commercializing the InTheZone brand, is now in place and available to founders. The company is expanding its advisory bench and strategic network to support the next phase of scaling NutraVeri, and expects to announce additional advisory relationships and strategic collaborations in the coming weeks.

NutraVeri provides a rapid NutraVeri Score assessing formulations across six dimensions, supported by regulatory intelligence, a Product Passport for documentation, access to FDA-registered, cGMP-aligned manufacturing partners, growing fulfillment capabilities, and an expanding partner ecosystem, with each component representing a potential revenue stream according to Nitches.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.27%
Tags
none
-
Rhea-AI Summary

Nitches (OTC:NICH) announced a strategic repositioning that makes its NutraVeri supplement technology platform the core of its long-term growth strategy, moving beyond its legacy apparel business. Built from the company's experience launching its own InTheZone supplement brand, NutraVeri provides founders with data-driven product validation, FDA-registered, cGMP-aligned manufacturing access, and commercialization support.

The platform delivers a NutraVeri Score in about 60 seconds across six readiness dimensions and integrates intelligence, documentation, manufacturing, fulfillment, and a partner network. Nitches plans to keep supporting InTheZone while investing in NutraVeri as its primary growth engine.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25%
Tags
none
-
Rhea-AI Summary

Nitches (OTC:NICH) announced that its NutraVeri founder platform is expanding beyond formulation, manufacturing, and regulatory readiness to include warehousing, fulfillment, and distribution, creating a single, integrated path from an initial 60-second readiness score to a finished supplement delivered to customers.

NutraVeri is in advanced discussions with a U.S. manufacturing organization that can support almost every lifecycle stage, from R&D and formulation through packaging, inventory management, shipping, and logistics. The platform offers over 200 white-label nutraceutical and OTC products plus private-label options, underpinned by FDA cGMP, NSF, ISO 9001, ISO/IEC 17025:2017 and United States Pharmacopeia-aligned quality systems. Founders receive a free NutraVeri Score that evaluates six dimensions—formula strength, ingredient evidence, dose validation, claim risk, label readiness, and market fit—using FDA and FTC resources to flag issues before capital is committed, then can proceed through commercialization without leaving the platform.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Nitches (OTC:NICH) highlighted its NutraVeri platform, a product readiness tool for dietary supplement founders responding to tighter FDA, FTC, and NAD enforcement. NutraVeri delivers a free, 60-second, six-dimensional readiness score using regulatory and scientific data, helping evaluate ingredients, doses, claims, and labels before manufacturing.

The workflow links concept, readiness score, a sharable Product Passport, and access to FDA-registered, cGMP-aligned manufacturing partners with smaller minimum runs for emerging brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.53%
Tags
none
-
Rhea-AI Summary

Nitches (OTC:NICH) operates NutraVeri, a supplement evaluation platform built around a deterministic Supplement Readiness Score. The same formula and claims always yield the same score, with every dimension traced to public FDA, FTC, NIH and scientific sources.

NutraVeri delivers a point-in-time, explainable readiness assessment in about sixty seconds, indexing 120+ ingredients with evidence context and claim-risk posture. It offers free initial assessments for founders and a new partner program for agencies, manufacturers, consultants, and other operators serving emerging supplement brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary

Nitches (OTC:NICH) announced NutraVeri, an AI-powered platform that generates a deterministic supplement readiness score. The same formula and claims always yield the same result, with six dimensions tied to public FDA, FTC, GRAS, NIH, and peer-reviewed sources.

NutraVeri lets founders change ingredients or claims and see which regulatory risk dimensions move, returning a score in about sixty seconds. According to Nitches, the first readiness score is free, takes about two minutes, and requires no account or credit card.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10%
Tags
AI
Rhea-AI Summary

Nitches (OTC PINK:NICH) launched NutraVeri, a platform that screens supplement formulas and marketing claims against public FDA and FTC enforcement records.

The tool scores concepts across six readiness dimensions, indexes 120+ ingredients, highlights high-risk issues, and offers a fast, free initial NutraVeri Score taking about two minutes with no account or payment required.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.33%
Tags
none
-
Rhea-AI Summary

Nitches (OTC PINK:NICH) announced an expanded NutraVeri Readiness Partner Program that pays manufacturers, agencies, creators, and advisors to refer supplement founders to a free product readiness score before they spend on formula, label, or inventory.

The tool generates a NutraVeri Score in about sixty seconds across six dimensions: formula strength, ingredient evidence, claim risk, dose validation, label readiness, and market fit, using FDA data sources and regulatory guidance. Partners earn tiered commissions when founders upgrade to paid services, and the first 25 approved applicants receive Founding Partner status with temporary enhanced front-end commission rates and priority review.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Nitches (OTC:NICH), via its NutraVeri platform, expanded its Readiness Partner Program, a selective affiliate network that sends supplement founders through a free product readiness score before committing capital.

Partners earn commissions on paid services such as advanced readiness reports, Product Passports, formula reviews, and manufacturing preparation support.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Nitches (OTC:NICH) launched NutraVeri, a product readiness platform that helps founders assess dietary supplement concepts before manufacturing and commercialization. Users submit ingredients, dosages, claims, and targets, and receive a NutraVeri Score across six dimensions, plus optional reports, human formula review, and manufacturing pathway evaluation.

The platform leverages publicly available scientific and regulatory references and offers an initial readiness assessment at no cost via nutraveri.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Nitches (NICH)?

The current stock price of Nitches (NICH) is $0.0018 as of July 24, 2026.

What is the market cap of Nitches (NICH)?

The market cap of Nitches (NICH) is approximately 517.8K.